公开(公告)号：US11593926B2

公开(公告)日：2023-02-28

申请号：US17566439

申请日：2021-12-30

Applicant: ELUCID BIOIMAGING INC.

Inventor： Andrew J. Buckler ,  Changguo Ji ,  Murali Ayyapillai

IPC: G06T5/50 ,  A61B6/00 ,  G06T7/00 ,  G06T7/174

Abstract: Systems and methods for improving soft tissue contrast, characterizing tissue, classifying phenotype, stratifying risk, and performing multi-scale modeling aided by multiple energy or contrast excitation and evaluation are provided. The systems and methods can include single and multi-phase acquisitions and broad and local spectrum imaging to assess atherosclerotic plaque tissues in the vessel wall and perivascular space.

公开(公告)号：US11257584B2

公开(公告)日：2022-02-22

申请号：US16102042

申请日：2018-08-13

Applicant: Elucid Bioimaging Inc.

Inventor： Mary E. Buckler ,  Xiaonan Ma ,  Lawrence Martell ,  Andrew J. Buckler

IPC: G06F40/30 ,  G16H50/20 ,  G16H30/20 ,  G06F16/36 ,  G06F16/332 ,  G06T7/00 ,  G06F40/211 ,  G06F40/242 ,  G06F40/284 ,  G16H15/00

Abstract: Advanced reporting systems based on ontology development for quantitative imaging biomarkers, information modeling to integrate heterogeneous data types relevant to quantitative medical analysis, and a knowledge representation framework for their statistical validation.

公开(公告)号：US11094058B2

公开(公告)日：2021-08-17

申请号：US16203418

申请日：2018-11-28

Applicant: Elucid Bioimaging Inc.

Inventor： Andrew J. Buckler ,  Kjell Johnson ,  Xiaonan Ma ,  Keith A. Moulton ,  Mark A. Buckler ,  Vladimir Valtchinov ,  David S. Paik

IPC: G06K9/00 ,  G06T7/00 ,  G06T7/11 ,  G06N20/00 ,  G06N3/08 ,  G06K9/32 ,  G06T5/00 ,  G06K9/62 ,  G06T3/00

Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.

公开(公告)号：US20190244347A1

公开(公告)日：2019-08-08

申请号：US16203418

申请日：2018-11-28

Applicant: Elucid Bioimaging Inc.

Inventor： Andrew J. Buckler ,  Kjell Johnson ,  Xiaonan Ma ,  Keith A. Moulton ,  Mark A. Buckler ,  Vladimir Valtchinov ,  David S. Paik

IPC: G06T7/00 ,  G06T7/11 ,  G06N20/00 ,  G06N3/08 ,  G06K9/32 ,  G06K9/00 ,  G06T5/00

CPC classification number: G06T7/0012 ,  G06K9/00127 ,  G06K9/3233 ,  G06K9/6228 ,  G06K9/6257 ,  G06K9/6267 ,  G06N3/08 ,  G06N20/00 ,  G06T3/00 ,  G06T5/003 ,  G06T7/11 ,  G06T2207/10048 ,  G06T2207/10081 ,  G06T2207/10088 ,  G06T2207/10101 ,  G06T2207/10104 ,  G06T2207/10108 ,  G06T2207/10132 ,  G06T2207/20081 ,  G06T2207/30096 ,  G06T2207/30104

Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.

公开(公告)号：US12125571B2

公开(公告)日：2024-10-22

申请号：US18232138

申请日：2023-08-09

Applicant: Elucid Bioimaging Inc.

Inventor： Andrew J. Buckler ,  Ulf Hedin ,  Ljubica Matic ,  Matthew Phillips

IPC: G16H20/10 ,  G16B5/00

CPC classification number: G16H20/10 ,  G16B5/00

Abstract: Provided herein are methods and systems for making patient-specific therapy recommendations of an anti-diabetic therapy for patients with known or suspected cardiovascular disease, such as atherosclerosis.

公开(公告)号：US12100149B2

公开(公告)日：2024-09-24

申请号：US18232246

申请日：2023-08-09

Applicant: Elucid Bioimaging Inc.

Inventor： Andrew J. Buckler ,  Ulf Hedin ,  Ljubica Matic ,  Matthew Phillips

IPC: G06T7/00 ,  A61B5/055 ,  G16B5/00 ,  G16C20/30 ,  G16H20/00

CPC classification number: G06T7/0012 ,  A61B5/055 ,  G16B5/00 ,  G16C20/30 ,  G16H20/00 ,  G06T2207/10088 ,  G06T2207/30101

Abstract: Provided herein are methods and systems for making patient-specific therapy recommendations of a combination of any two or more therapies selected from a lipid-lowering therapy, an anti-inflammatory therapy for patients with known or suspected cardiovascular disease, such as atherosclerosis.

公开(公告)号：US12073561B2

公开(公告)日：2024-08-27

申请号：US18166284

申请日：2023-02-08

Applicant: ELUCID BIOIMAGING INC.

Inventor： Andrew J. Buckler ,  Kjell Johnson ,  Xiaonan Ma ,  Keith A. Moulton ,  Mark A. Buckler ,  Vladimir Valtchinov ,  David S. Paik

IPC: G06T7/00 ,  G06F18/211 ,  G06F18/214 ,  G06F18/24 ,  G06N3/08 ,  G06N20/00 ,  G06T3/00 ,  G06T5/73 ,  G06T7/11 ,  G06V10/25 ,  G06V10/764 ,  G06V20/69

CPC classification number: G06T7/0012 ,  G06F18/211 ,  G06F18/2148 ,  G06F18/24 ,  G06N3/08 ,  G06N20/00 ,  G06T3/00 ,  G06T5/73 ,  G06T7/11 ,  G06V10/25 ,  G06V10/764 ,  G06V20/69 ,  G06T2207/10048 ,  G06T2207/10081 ,  G06T2207/10088 ,  G06T2207/10101 ,  G06T2207/10104 ,  G06T2207/10108 ,  G06T2207/10132 ,  G06T2207/20081 ,  G06T2207/30096 ,  G06T2207/30104

Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.

公开(公告)号：US20240078673A1

公开(公告)日：2024-03-07

申请号：US18504811

申请日：2023-11-08

Applicant: ELUCID BIOIMAGING INC.

Inventor： Andrew J. BUCKLER ,  Kjell JOHNSON ,  Xiaonan MA ,  Keith A. MOULTON ,  David S. PAIK

IPC: G06T7/00 ,  G06F18/211 ,  G06F18/214 ,  G06F18/24 ,  G06N3/08 ,  G06N20/00 ,  G06T3/00 ,  G06T5/00 ,  G06T7/11 ,  G06V10/25 ,  G06V10/764 ,  G06V20/69

CPC classification number: G06T7/0012 ,  G06F18/211 ,  G06F18/2148 ,  G06F18/24 ,  G06N3/08 ,  G06N20/00 ,  G06T3/00 ,  G06T5/003 ,  G06T7/11 ,  G06V10/25 ,  G06V10/764 ,  G06V20/69 ,  G06T2207/10048 ,  G06T2207/10081 ,  G06T2207/10088 ,  G06T2207/10101 ,  G06T2207/10104 ,  G06T2207/10108 ,  G06T2207/10132 ,  G06T2207/20081 ,  G06T2207/30096 ,  G06T2207/30104

Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.

公开(公告)号：US20240078672A1

公开(公告)日：2024-03-07

申请号：US18504802

申请日：2023-11-08

Applicant: ELUCID BIOIMAGING INC.

Inventor： Andrew J. BUCKLER ,  Kjell JOHNSON ,  Xiaonan MA ,  Keith A. MOULTON ,  David S. PAIK

IPC: G06T7/00 ,  G06F18/211 ,  G06F18/214 ,  G06F18/24 ,  G06N3/08 ,  G06N20/00 ,  G06T3/00 ,  G06T5/00 ,  G06T7/11 ,  G06V10/25 ,  G06V10/764 ,  G06V20/69

CPC classification number: G06T7/0012 ,  G06F18/211 ,  G06F18/2148 ,  G06F18/24 ,  G06N3/08 ,  G06N20/00 ,  G06T3/00 ,  G06T5/003 ,  G06T7/11 ,  G06V10/25 ,  G06V10/764 ,  G06V20/69 ,  G06T2207/10048 ,  G06T2207/10081 ,  G06T2207/10088 ,  G06T2207/10101 ,  G06T2207/10104 ,  G06T2207/10108 ,  G06T2207/10132 ,  G06T2207/20081 ,  G06T2207/30096 ,  G06T2207/30104

Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.

公开(公告)号：US20240062901A1

公开(公告)日：2024-02-22

申请号：US18242386

申请日：2023-09-05

Applicant: Elucid Bioimaging Inc.

Inventor： Andrew J. Buckler ,  Ulf Hedin ,  Ljubica Matic ,  Matthew Phillips

IPC: G16H50/20 ,  G16H20/10 ,  G16H50/50 ,  G06N20/00

CPC classification number: G16H50/20 ,  G16H20/10 ,  G16H50/50 ,  G06N20/00 ,  A61B6/504

Abstract: Provided herein are methods and systems for making patient-specific therapy recommendations of a lipid-lowering therapy for patients with known or suspected cardiovascular disease, such as atherosclerosis.